319 related articles for article (PubMed ID: 33746905)
1. Risk Factors for Central and Lateral Lymph Node Metastases in Patients With Papillary Thyroid Micro-Carcinoma: Retrospective Analysis on 484 Cases.
Huang Y; Yin Y; Zhou W
Front Endocrinol (Lausanne); 2021; 12():640565. PubMed ID: 33746905
[TBL] [Abstract][Full Text] [Related]
2. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
3. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
4. Lateral lymph node metastasis in papillary thyroid microcarcinoma: a study of 5241 follow-up patients.
Ruan J; Chen Z; Chen S; Xu Z; Wen L; Mao Z; Shen J; Liu J; Wang W
Endocrine; 2024 Feb; 83(2):414-421. PubMed ID: 37596455
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
6. Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy.
Gong Y; Yang J; Yan S; Su A; Liu F; Gong R; Zhu J; Li Z
Medicine (Baltimore); 2018 Sep; 97(36):e12263. PubMed ID: 30200164
[TBL] [Abstract][Full Text] [Related]
7. Clinical and pathologic predictors of lymph node metastasis in papillary thyroid microcarcinomas.
Zhao L; Sun X; Luo Y; Wang F; Lyu Z
Ann Diagn Pathol; 2020 Dec; 49():151647. PubMed ID: 33126150
[TBL] [Abstract][Full Text] [Related]
8. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
[TBL] [Abstract][Full Text] [Related]
9. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.
Luo Y; Zhao Y; Chen K; Shen J; Shi J; Lu S; Lei J; Li Z; Luo D
J Endocrinol Invest; 2019 Feb; 42(2):227-236. PubMed ID: 29876836
[TBL] [Abstract][Full Text] [Related]
10. Risk factors associated with preferential lateral lymph node metastasis in papillary thyroid carcinoma.
Shao L; Wang Z; Dong W; Sun W; Zhang H
Cancer Med; 2023 Nov; 12(22):20670-20676. PubMed ID: 37905599
[TBL] [Abstract][Full Text] [Related]
11. Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis.
Back K; Kim JS; Kim JH; Choe JH
Ann Surg Oncol; 2019 Nov; 26(12):3992-4001. PubMed ID: 31264121
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients.
Zhang L; Wei WJ; Ji QH; Zhu YX; Wang ZY; Wang Y; Huang CP; Shen Q; Li DS; Wu Y
J Clin Endocrinol Metab; 2012 Apr; 97(4):1250-7. PubMed ID: 22319042
[TBL] [Abstract][Full Text] [Related]
13. Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?
Chang YW; Kim HS; Kim HY; Lee JB; Bae JW; Son GS
Asian J Surg; 2016 Oct; 39(4):197-201. PubMed ID: 25913730
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma: A Retrospective Chinese Cohort Study.
Zhu F; Shen YB; Li FQ; Fang Y; Hu L; Wu YJ
Medicine (Baltimore); 2016 Feb; 95(6):e2674. PubMed ID: 26871795
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis.
Wang Y; Zheng J; Hu X; Chang Q; Qiao Y; Yao X; Zhou X
Eur J Surg Oncol; 2023 Mar; 49(3):560-567. PubMed ID: 36404253
[TBL] [Abstract][Full Text] [Related]
16. Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study.
Zhou YL; Gao EL; Zhang W; Yang H; Guo GL; Zhang XH; Wang OC
World J Surg Oncol; 2012 May; 10():67. PubMed ID: 22540396
[TBL] [Abstract][Full Text] [Related]
17. Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.
Nie X; Tan Z; Ge M
BMC Cancer; 2017 Oct; 17(1):702. PubMed ID: 29070029
[TBL] [Abstract][Full Text] [Related]
18. Nomogram for predicting central lymph node metastasis in papillary thyroid microcarcinoma: A retrospective cohort study of 8668 patients.
Wang Y; Guan Q; Xiang J
Int J Surg; 2018 Jul; 55():98-102. PubMed ID: 29803769
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1-2 Central Lymph Node Metastases.
Wang Y; Deng C; Shu X; Yu P; Wang H; Su X; Tan J
Front Endocrinol (Lausanne); 2021; 12():716728. PubMed ID: 34721289
[TBL] [Abstract][Full Text] [Related]
20. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.
Feng JW; Ye J; Wu WX; Qu Z; Qin AC; Jiang Y
J Endocrinol Invest; 2020 Dec; 43(12):1807-1817. PubMed ID: 32557354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
